Perrigo announces launch of AB rated generic version of Topicort® topical spray 0.2
Perrigo announced the launch of an AB-rated generic version of Topicort® (desoximetasone)Topical Spray 0.25%. Topicort® Topical Spray is indicated for treatment of plaque psoriasis in patients 18 years of age or older. Annual market sales ending October 2018 were $18 million as measured by IQVIA™. December 10, 2018